BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15389242)

  • 1. A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunction.
    Atisha D; Bhalla MA; Morrison LK; Felicio L; Clopton P; Gardetto N; Kazanegra R; Chiu A; Maisel AS
    Am Heart J; 2004 Sep; 148(3):518-23. PubMed ID: 15389242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-type natriuretic peptide level in the diagnosis of asymptomatic diastolic dysfunction.
    Karaca I; Gülcü E; Yavuzkir M; Dağli N; Ilkay E; Ozbay Y; Işik A; Arslan N
    Anadolu Kardiyol Derg; 2007 Sep; 7(3):262-7. PubMed ID: 17785213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction.
    Maisel AS; Koon J; Krishnaswamy P; Kazenegra R; Clopton P; Gardetto N; Morrisey R; Garcia A; Chiu A; De Maria A
    Am Heart J; 2001 Mar; 141(3):367-74. PubMed ID: 11231433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible role of BNP for an early diagnosis of asymptomatic left ventricular dysfunction: a retrospective study.
    De Vecchis R; Esposito C; Ariano C; Di Biase G
    Minerva Cardioangiol; 2014 Apr; 62(2):147-59. PubMed ID: 24686994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes.
    Epshteyn V; Morrison K; Krishnaswamy P; Kazanegra R; Clopton P; Mudaliar S; Edelman S; Henry R; Maisel A
    Diabetes Care; 2003 Jul; 26(7):2081-7. PubMed ID: 12832317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings.
    Mak GS; DeMaria A; Clopton P; Maisel AS
    Am Heart J; 2004 Nov; 148(5):895-902. PubMed ID: 15523324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide].
    Tarantini L; Cioffi G; Di Lenarda A; Valle R; Pulignano G; Del Sindaco D; Frigo G; Soravia G; Tessier R; Catania G
    G Ital Cardiol (Rome); 2008 Dec; 9(12):835-43. PubMed ID: 19119693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrocardiogram and B-type natriuretic peptide as screening tools for left ventricular systolic dysfunction in a population-based sample of 75-year-old men and women.
    Hedberg P; Lönnberg I; Jonason T; Nilsson G; Pehrsson K; Ringqvist I
    Am Heart J; 2004 Sep; 148(3):524-9. PubMed ID: 15389243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
    Romano S; Necozione S; Guarracini L; Fratini S; Cisternino P; di Orio F; Penco M
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of brain-natriuretic peptide for left ventricular diastolic dysfunction in asymptomatic type 2 diabetic patients.
    Shimabukuro M; Higa N; Oshiro Y; Asahi T; Takasu N
    Diabetes Obes Metab; 2007 May; 9(3):323-9. PubMed ID: 17391158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bedside tests of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients.
    Wei T; Zeng C; Chen L; Chen Q; Zhao R; Lu G; Lu C; Wang L
    Eur J Heart Fail; 2005 Jan; 7(1):75-9. PubMed ID: 15642535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of brain natriuretic peptide as a screening test for left ventricular systolic dysfunction- cost-effectiveness in relation to open access echocardiography.
    Sim V; Hampton D; Phillips C; Lo SN; Vasishta S; Davies J; Penney M
    Fam Pract; 2003 Oct; 20(5):570-4. PubMed ID: 14507800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic ability of B-type natriuretic peptide and impedance cardiography: testing to identify left ventricular dysfunction in hypertensive patients.
    Bhalla V; Isakson S; Bhalla MA; Lin JP; Clopton P; Gardetto N; Maisel AS
    Am J Hypertens; 2005 Feb; 18(2 Pt 2):73S-81S. PubMed ID: 15752936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systolic and diastolic heart failure are associated with different plasma levels of B-type natriuretic peptide.
    Wei T; Zeng C; Chen L; Chen Q; Zhao R; Lu G; Lu C; Wang L
    Int J Clin Pract; 2005 Aug; 59(8):891-4. PubMed ID: 16033608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of brain natriuretic peptide after acute myocardial infarction.
    Güneş Y; Okçün B; Kavlak E; Erbaş C; Karcier S
    Anadolu Kardiyol Derg; 2008 Jun; 8(3):182-7. PubMed ID: 18524723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction.
    Krishnaswamy P; Lubien E; Clopton P; Koon J; Kazanegra R; Wanner E; Gardetto N; Garcia A; DeMaria A; Maisel AS
    Am J Med; 2001 Sep; 111(4):274-9. PubMed ID: 11566457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides.
    Ng LL; Loke IW; Davies JE; Geeranavar S; Khunti K; Stone MA; Chin DT; Squire IB
    J Am Coll Cardiol; 2005 Apr; 45(7):1043-50. PubMed ID: 15808762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal pro-B-type natriuretic peptide as a diagnostic test for ventricular dysfunction in patients with coronary disease: data from the heart and soul study.
    Corteville DC; Bibbins-Domingo K; Wu AH; Ali S; Schiller NB; Whooley MA
    Arch Intern Med; 2007 Mar; 167(5):483-9. PubMed ID: 17353496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population.
    Nielsen OW; McDonagh TA; Robb SD; Dargie HJ
    J Am Coll Cardiol; 2003 Jan; 41(1):113-20. PubMed ID: 12570953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings.
    Lubien E; DeMaria A; Krishnaswamy P; Clopton P; Koon J; Kazanegra R; Gardetto N; Wanner E; Maisel AS
    Circulation; 2002 Feb; 105(5):595-601. PubMed ID: 11827925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.